The SYBHEL project is comprised of researchers from several European institutions;
The University of Bristol in the United Kingdom (Coordinator)
The University of Zurich in Switzerland
The University of Deusto in Spain
The Rathenau Institute in the Netherlands
Alex Calladine is the project manager and a research associate on the SYBHEL project. His background is in philosophy and jurisprudence. At UCL he taught courses on the Ethical Dilemmas of Genetic Intervention in the Faculty of Laws and Policy Issues in the Life Sciences in the Department of Science and Technology Studies. His principle research interests are in jurisprudence and applied philosophy. He is particularly interested in questions raised by the impact of current and (possible) future technologies on both individual people and society, particularly with regards to medicine, psychiatry, behaviour modification and social control. More here
Ainsley Newson has degrees in Science and Law and a PhD in Medical Ethics. She has research interests in genetics and biotechnology, human reproduction, clinical ethics and public health ethics and she has published on these issues in a range of academic journals and monographs. Ainsley is Senior Lecturer in Biomedical Ethics at the Centre for Ethics in Medicine, where her responsibilities include coordinating undergraduate and Masters-level courses in health care ethics. She is a member of numerous national and international committees relevant to ethics, including the Management Committee of the Synthetic Components Network in Bristol.
Ruud ter Meulen is a social scientist and ethicist and Director/Chair at the Centre for Ethics in Medicine. He Directed the Institute for Bioethics at the University of Maastricht (1995-2005). He has research interests in autonomy and elderly care, resource allocation, ethics committees and ethical pluralism; and he has published on these issues in a range of academic journals and monographs. He sits on a range of national and international committees in medical ethics and is actively involved in training and consultancy in health care ethics.
Heather Bradshaw-Martin has studied philosophy and engineering. She has an undergraduate degree in Politics, Philosophy and Economics from the University of Oxford, studied Health Care Ethics at Bristol and is just completing a bioethics PhD in the field of enhancement. She has published in places such as the Journal of Medicine and Philosophy and Nature.
Professor Nikola Biller-Andorno studied medicine at the University of Erlangen-Nuernberg as well as philosophy and social sciences at the University of Hagen, Germany. Multiple scholarships and awards allowed her to pursue her research interests at prestigious institutions such as the Hastings Center (1994), Yale University (1997) and the Harvard Medical School (1997-98). After her “habilitation” in ethics and theory of medicine at the University of Göttingen, Germany, she worked as Ethicist at the World Health Organization (2002-2004). In 2004 she was appointed Professor of Medical Ethics at the Charité, Joint Medical Faculty of the Free and Humboldt University, Berlin, Germany. In October 2005 she joined the University of Zurich as Full Professor of Biomedical Ethics. She serves as temporary advisor to the WHO and as deputy editor of the Journal of Medical Ethics.
Anna Deplazes studied Molecular Biology, Zoology (Genetics and Developmental Biology) at the University of Zurich (1998-2003). She did her PhD at the Institute of Biochemistry at the ETH, Zurich (2003-2007). Since 2007 she has a fellowship of the Graduate Programme for interdisciplinary Research in Ethics of the URPP Ethics (University Research Programme in Ethics) at the University of Zurich, where she is working on a project on ethical issues raised by synthetic biology. From 2007-8 she was associated with SYNBIOSAFE (FP6). Besides her work on ethics of synthetic biology she studies Philosophy at the University of Zurich.
Daniel Gregorowius studied Geography, Biology, Environmental Psychology and Environmental Ethics in Bochum and Zurich. In March 2007, he started his PhD project on ethical arguments in the ecological debate on the use of GM crops at the Institute for Evolutionary Biology and Environmental Studies at the University of Zurich. He completed the Graduate Programme for interdisciplinary Research in Ethics of the URPP Ethics (University Research Programme in Ethics) at the University of Zurich. Daniel has organized several literature seminars and gave lectures for undergraduate students in Environmental Psychology at the University of Zurich.
Professor Carlos Maria Romeo Casabona is a Dr. in law, Professor of Criminal Law. Director of the Interuniversity Chair in Law and the Human Genome. Member of several international institutions devoted to the study and evaluation of legal and ethical issues of biotechnology. Expertise on international, European and national biolaw.
Iñigo de Miguel is a Researcher and Member of the Interuniversity Chair in Law and the Human Genome. He has expertise in international, European and national biolaw, in particular: cloning, genetic engineering, patents and regenerative medicine.
Pilar Nicolás is a Researcher and Member of the Interuniversity Chair in Law and the Human Genome. She has expertise in international, European and national biolaw, in particular: use of human material for biomedical research, biobanks and patients’ rights.
Dr Stemerding is a biologist with expertise in the field of science & technology studies (STS). He is a senior researcher in Technology Assessment at the Rathenau Institute (RI) and is involved at the University of Twente in STS research focussing on genomics in health care. At the RI he works on societal aspects of SynBio, biotechnology, genomics and the biobased economy.
Conor joined the Rathenau Institute as a Post-Doctoral Researcher in the fall of 2010, and is working alongside Dr. Dirk Stemerding on 6th work package of the project related to the impacts of synthetic biology and European health and innovation policy. Conor is an STSer (science & technology studies) and takes a social science approach to his work on new genetic medical technologies like synbio, bio-banking, pharmacogenetics, and translational science. He also has a cross postdoc appointment with the Section Community Genetics at the Vrije University of Amsterdam.